In particular, it has been demonstrated that human T cells with a high expression of CD26 on their cell surface produce a great quantity of cytokine IL-17, suggesting that the CD26 expression on CD4+ T cells could contribute to tumor regression [26]. This evidence concerns the gene DPP4 and neoplasm.